Molecular dynamics and in silico mutagenesis on the reversible inhibitor-bound SARS-CoV-2 main protease complexes reveal the role of lateral pocket in enhancing the ligand affinity
- PMID: 33795718
- PMCID: PMC8016996
- DOI: 10.1038/s41598-021-86471-0
Molecular dynamics and in silico mutagenesis on the reversible inhibitor-bound SARS-CoV-2 main protease complexes reveal the role of lateral pocket in enhancing the ligand affinity
Abstract
The 2019 novel coronavirus pandemic caused by SARS-CoV-2 remains a serious health threat to humans and there is an urgent need to develop therapeutics against this deadly virus. Recent scientific evidences have suggested that the main protease (Mpro) enzyme in SARS-CoV-2 can be an ideal drug target due to its crucial role in the viral replication and transcription processes. Therefore, there are ongoing research efforts to identify drug candidates against SARS-CoV-2 Mpro that resulted in hundreds of X-ray crystal structures of ligand-bound Mpro complexes in the Protein Data Bank (PDB) describing the interactions of different fragment chemotypes within different sites of the Mpro. In this work, we performed rigorous molecular dynamics (MD) simulation of 62 reversible ligand-Mpro complexes in the PDB to gain mechanistic insights about their interactions at the atomic level. Using a total of over 3 µs long MD trajectories, we characterized different pockets in the apo Mpro structure, and analyzed the dynamic interactions and binding affinity of ligands within those pockets. Our results identified the key residues that stabilize the ligands in the catalytic sites and other pockets of Mpro. Our analyses unraveled the role of a lateral pocket in the catalytic site in Mpro that is critical for enhancing the ligand binding to the enzyme. We also highlighted the important contribution from HIS163 in the lateral pocket towards ligand binding and affinity against Mpro through computational mutation analyses. Further, we revealed the effects of explicit water molecules and Mpro dimerization in the ligand association with the target. Thus, comprehensive molecular-level insights gained from this work can be useful to identify or design potent small molecule inhibitors against SARS-CoV-2 Mpro.
Conflict of interest statement
The authors declare no competing interests.
Figures
Similar articles
-
Covalent and non-covalent binding free energy calculations for peptidomimetic inhibitors of SARS-CoV-2 main protease.Phys Chem Chem Phys. 2021 Mar 21;23(11):6746-6757. doi: 10.1039/d1cp00266j. Epub 2021 Mar 12. Phys Chem Chem Phys. 2021. PMID: 33711090
-
Development of Effective Therapeutic Molecule from Natural Sources against Coronavirus Protease.Int J Mol Sci. 2021 Aug 30;22(17):9431. doi: 10.3390/ijms22179431. Int J Mol Sci. 2021. PMID: 34502340 Free PMC article.
-
In Silico Mining of Terpenes from Red-Sea Invertebrates for SARS-CoV-2 Main Protease (Mpro) Inhibitors.Molecules. 2021 Apr 5;26(7):2082. doi: 10.3390/molecules26072082. Molecules. 2021. PMID: 33916461 Free PMC article.
-
Are protein-ligand docking programs good enough to predict experimental poses of noncovalent ligands bound to the SARS-CoV-2 main protease?Drug Discov Today. 2024 Oct;29(10):104137. doi: 10.1016/j.drudis.2024.104137. Epub 2024 Aug 14. Drug Discov Today. 2024. PMID: 39151594 Review.
-
Artificial intelligence in the prediction of protein-ligand interactions: recent advances and future directions.Brief Bioinform. 2022 Jan 17;23(1):bbab476. doi: 10.1093/bib/bbab476. Brief Bioinform. 2022. PMID: 34849575 Free PMC article. Review.
Cited by
-
Identifying Potential Human Monoacylglycerol Lipase Inhibitors from the Phytoconstituents of Morinda Citrifolia L. Fruits by in silico Pharmacology and in vitro Study.J Exp Pharmacol. 2024 Sep 23;16:295-309. doi: 10.2147/JEP.S477956. eCollection 2024. J Exp Pharmacol. 2024. PMID: 39345798 Free PMC article.
-
Mapping protein conformational landscapes from crystallographic drug fragment screens.bioRxiv [Preprint]. 2024 Jul 30:2024.07.29.605395. doi: 10.1101/2024.07.29.605395. bioRxiv. 2024. PMID: 39131376 Free PMC article. Preprint.
-
In Silico Exploration of Isoxazole Derivatives of Usnic Acid: Novel Therapeutic Prospects Against α-Amylase for Diabetes Treatment.Cell Biochem Biophys. 2024 Jul 17. doi: 10.1007/s12013-024-01419-1. Online ahead of print. Cell Biochem Biophys. 2024. PMID: 39020086
-
Structure-Based Discovery of Allosteric Inhibitors Targeting a New Druggable Site in the Respiratory Syncytial Virus Polymerase.ACS Omega. 2024 May 6;9(20):22213-22229. doi: 10.1021/acsomega.4c01207. eCollection 2024 May 21. ACS Omega. 2024. PMID: 38799318 Free PMC article.
-
Identification of Phytochemicals from Arabian Peninsula Medicinal Plants as Strong Binders to SARS-CoV-2 Proteases (3CLPro and PLPro) by Molecular Docking and Dynamic Simulation Studies.Molecules. 2024 Feb 25;29(5):998. doi: 10.3390/molecules29050998. Molecules. 2024. PMID: 38474509 Free PMC article.
References
-
- WHO Coronavirus Disease (COVID-19) Dashboard | WHO Coronavirus Disease (COVID-19) Dashboard. https://covid19.who.int/.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous